On November 24, 2015, the comment period for rulemaking on PAMA Section 216 - new law for new pricing of the Clinical Laboratory Fee schedule.
1293 comments were submitted to CMS and are
online. I culled about 40 of the corporate comments - such as from ACLA, AMA, Advamed, BCBS, American Hospital Assocation, CAP, AMP, NILA, and others - and you can find them bundled in a 17MB zip file in the cloud:
here.
By page count, below.
| NILA AAB |
26 |
| ACLA |
32 |
| Advamed |
14 |
| AHA |
7 |
| AIT |
5 |
| Allstate |
5 |
| AMA |
10 |
| AMP |
5 |
| AOA |
3 |
| APEX |
4 |
| Artlab |
5 |
| ASCLS |
5 |
| ASCP |
9 |
| BCBSA |
3 |
| BHA |
4 |
| BIO |
6 |
| BostonHeart |
5 |
| BP Lab |
3 |
| C21 |
24 |
| CAP |
14 |
| CCLA |
3 |
| CHA |
4 |
| CLMA |
4 |
| CodeMap_POCC |
9 |
| FAH |
5 |
| GENETWx |
12 |
| HAP |
4 |
| HCA NY |
2 |
| HNL |
5 |
| IDSA |
4 |
| InterMt |
2 |
| Mckesson |
5 |
| Meridian |
2 |
| Metamark |
7 |
| MGMA |
4 |
| NASL |
3 |
| NCCL |
5 |
| NICL |
14 |
| NIHB |
14 |
| PGBA |
5 |
| PMC |
10 |
| Quest |
4 |
| Roche |
5 |
___
321 pp |
|
|
|
|
|
